The DOI matches its Crossref record; 153 of the 159 references it cites were found in a registry or an index.
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability
Abstract
Background A meta-analysis of the efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) against tricyclic antidepressants (TCAs) in depressed patients was carried out. Methods Efficacy data from 102 randomised controlled trials (10706 patients) were pooled to provide a summary variance-weighted effect size. Tolerability data from 95 studies (10553 patients) were combined to give variance-weighted relative risk of drop out for all reasons and for adverse effects from each study. The effect of age, treatment setting, severity and TCA dose were examined as well as the performance of individual SSRIs and TCAs where there were sufficient studies. Results There is no overall difference in efficacy between SSRIs and TCAs (effect size -0.03, 95% confidence interval -0.09 to 0.03). TCAs do appear more effective in in-patients (-0.23, -0.40 to -0.05) and amitriptyline is more effective than SSRI comparators (-0.14, -0.25 to -0.03) but publication bias cannot be excluded. The SSRIs are better tolerated, with significantly lower rates of treatment discontinuations overall (relative risk 0.88, 0.83 to 0.93; number needed to treat 26) and due to side effects (0.73, 0.67 to 0.80; number needed to treat 33). Individual SSRIs show a similar advantage except for fluvoxamine which does not differ from the TCAs. Individual TCAs show a similar disadvantage in tolerability compared to SSRIs except for dothiepin against which SSRI treatment results in more side-effect related…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, studies have found that between 27 and 31% of patients taking antidepressant medication discontinue treatment because of side effects (Anderson, 2000; MacGillivray et al., 2003).”
From A mindful yoga intervention for young women with major depressive disorder: Design and baseline sample characteristics of a randomized controlled trial (2020) · cites this paper as Anderson, 2000
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,377
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
Diagnostic criteria for use in psychiatric research.
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G., & Munoz, R. A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750190059011 · Cited by 5,491
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,840
Spitzer, R. L., Endicott, J., & Robins, E. (1978) · PsycTESTS Dataset · doi:10.1037/t04137-000 · Cited by 556
Recognition and management of depression in general practice: consensus statement
Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Danish University Antidepressant Group (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90081-i · Cited by 398
Research works printed but not linked: 14
- Amin, 1984, Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study, Clin. Neuropharmacol., 7, S316
- Anderson, 1998, A meta-analysis of controlled trials comparing SSRIs in the treatment of depression, J. Psychopharmacol., 12, A20
- Dowling, 1990, Fluoxetine: a comparative study with dothiepin, Irish J. Psychiatry, Spring, 3
- 1993, The treatment of depression in primary care, Effective Health Care Bull., 5, 1
- Fawcett, 1989, Fluoxetine versus amitriptyline in adult out-patients with major depression, Curr. Ther. Res., 45, 821
- Ginestet, 1989, Fluoxetine in endogenous depression melancholia versus clomipramine, Int. Clin. Psychopharmacol., 4, 37
- Harris, 1991, Fluvoxamine versus amitriptyline in depressed hospital out-patients: A multicentre double-blind comparative trial, Br. J. Clin. Res., 2, 89
- Hutchinson, 1991, A double blind study in general practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients, Br. J. Clin. Res., 2, 43
- Masco, 1985, Double-blind comparison of fluoxetine and amitriptyline in the treatment of major depressive illness, Adv. Ther., 2, 275
- Pakesch, 1991, Depressive syndrome in a clinical trial with private practitioners. [German] OT – Wirkung und Sicherheit von Fluoxetin versus Clomipramin bei ambulanten Patienten mit einem depressiven Syndrom in einer klinischen Prufung bei niedergelassenen Arzten, Wien. Klin. Wochenschr., 103, 176
- Pélicier, 1993, Etude multicentrique en double aveugle comparant l’efficacité et la tolerance de la paroxetine et de la clomipramine dans la dépression réactionnelle du sujet âgé, L’Encéphale, XIX, 257
- Peters, 1990, Therapy of depression in the psychiatrist’s office – A double-blind multicenter study, Nervenheilkunde, 9, 28
- Remick, 1989, A comparison between fluoxetine and doxepin in depressed patients, Curr. Ther. Res., 46, 842
- Taneri, 1989, Fluoxetine versus nomifensine in out-patients with neurotic or reactive depression disorder, Int. Clin. Psychopharmacol., 4, 56
Cited by
Sorted by citations
Items 601–700 of 941
Berger, T., van Calker, D., Brakemeier, E., & Schramm, E. (2012) · Elsevier eBooks · doi:10.1016/b978-3-437-22483-6.10011-7 · Cited by 1
Sleep and circadian dysregulation in depressive illness : pharmacological implications
Cardinali, D. P., Pandi-Perumal, S. R., & Brown, G. M. (2011) · Americanae (AECID Library) · Cited by 1
Glial Cells in the Schizophrenia Puzzle: Angiotensin II Role
Occhieppo, V. B., Basmadjian, O. M., Marchese, N. A., Rodríguez, A., Jaime, A., Herrera, M., & Bregonzio, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_16 · Cited by 1
Ujeyl, M., & Müller-Oerlinghausen, B. (2012) · Der Schmerz · Cited by 1
Lohse, M. J., & Müller-Oerlinghausen, B. (2012) · Springer eBooks · doi:10.1007/978-3-642-29242-2_39 · Cited by 1
Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_67 · Cited by 2
Tricyclics: Imipramine, Clomipramine, Trimipramine (Dibenzazepines)
Volz, H., & Laux, G. (2022) · Springer eBooks · doi:10.1007/978-3-319-56015-1_385-1 · Cited by 1
Karataş, Y., Khan, Z., & Khan, F. U. (2022) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.1112770 · Cited by 1
Chapter 11. Tricyclic and Tetracyclic Drugs
Nelson, J. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as11 · Cited by 2
Relevant Pharmacology and Interventions
Watson, A., & Hand, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-72862-4_3 · Cited by 1
Dasgupta, A., & Lawson, K. A. (2013) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12010 · Cited by 1
Simultaneous Detection of Tricyclic Antidepressants using Higher Performance Liquid Chromatography
Sulayman, J. M. (2016) · International Journal of Pure & Applied Bioscience · doi:10.18782/2320-7051.2413 · Cited by 1
Major Depresif Bozukluk Tedavisinde Yetersiz Yanıtın Yönetimi ve Yeni Tedavi Seçenekleri
Karamustafalıoğlu, O., & Yavuz, B. G. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.1080/10177833.2011.11790745 · Cited by 1
Fedotova, J. (2020) · The Open Biology Journal · doi:10.2174/1874196702008010029 · Cited by 1
Outcomes in the Treatment of Major Depressive Disorder
Thase, M. E., & Koenig, A. M. (2009) · Medical psychiatry · doi:10.3109/9781420084887.002 · Cited by 1
Hosseini, F., Amini, F., Ardekani, S. M. Y., Shariat, N., & Sakhvidi, M. N. (2015) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.9(2)2015.1041 · Cited by 1
Nash, J. R., & Nutt, D. (2004) · Psychiatry · doi:10.1383/psyt.3.7.22.42882 · Cited by 1
Fagiolini, A. M., Amodeo, G., & Maina, G. (2017) · doi:10.1093/med/9780198746638.003.0010 · Cited by 1
Antidepressants, mood-stabilizing drugs, and mitochondrial functions: For better or for worse
Preston, G. J., Sabbagh, D. E. S. E., Emmerzaal, T. L., Morava, É., Andreazza, A. C., Rahman, S., & Kozicz, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88462-4.00016-x · Cited by 1
Antidepressant-Antianxiety Agents
Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_4 · Cited by 1
Diefenbacher, A., Burian, R., Klesse, C., & Härter, M. C. (2009) · Elsevier eBooks · doi:10.1016/b978-343722481-2.50033-7 · Cited by 1
Selektive Serotonin-Wiederaufnahmehemmer bei therapieresistenten und schweren Depressionen
Pfennig, A., Bauer, M., & Baethge, C. (2005) · Springer eBooks · doi:10.1007/3-540-28049-9_15 · Cited by 1
Brand, S. J. (2011) · Cited by 1
An Examination of the Acute Effects of Bright Light Therapy in a Non-Clinical Sample
Botanov, Y. (2011) · KU ScholarWorks (The University of Kansas) · Cited by 1
Thrasher, S. M. (2010) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16984594 · Cited by 1
Evidence-based medicine and routine clinical practice: the case of new antidepressant drugs
Barbui, C. (2002) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00005650 · Cited by 1
Retrospective Cohort Study of Venlafaxine, Fluoxetine or Sertraline in Long-Term Care
Blake, L. M., Wan, G. J., Panish, J. M., & Buatti, M. C. (2003) · Clinical Drug Investigation · doi:10.2165/00044011-200323110-00006 · Cited by 1
Long term studies of depression: what is relevant for the physician?
Fakra, É., Fonséca, D. D., Livolsi, S., Destoppeleire, C., & Lançon, C. (2006) · The European Journal of Psychiatry · doi:10.4321/s0213-61632006000400005 · Cited by 1
Analysis of Antidepressant Use Through Hierarchical Disease Analysis
Armstrong, E. P. (2001) · Disease Management & Health Outcomes · doi:10.2165/00115677-200109050-00003 · Cited by 1
Pinder, R. M. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2004.00091.x · Cited by 1
Selective serotonin re-uptake inhibitors in anxiety disorders: room for improvement
Baldwin, D. S., & Birtwistle, J. (2000) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8470-9_5 · Cited by 1
Henry, P. D., & Pacifico, A. (2002) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-1055-0_14 · Cited by 1
Towse, A. (2015) · SSRN Electronic Journal · doi:10.2139/ssrn.2637910 · Cited by 1
Psychopharmakologische Behandlung nicht respondierender depressiver Patienten
Laux, G. (2005) · Vandenhoeck & Ruprecht eBooks · doi:10.13109/9783666451645.192 · Cited by 1
The Tricyclics: More than Just Antidepressants
Plattner, A., & Dantz, B. (2011) · Psychiatric Annals · doi:10.3928/00485713-20110224-05 · Cited by 1
Developing Serotonergic Antidepressants Acting on More Than the Serotonin Transporter
Marek, G. J. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674381.ch12 · Cited by 1
Depressive Kernsymptome : Wirksamkeit medikamentöser antidepressiver Therapieverfahren
Damm, J., Eser, D., Schüle, C., Möller, H.-J., Rupprecht, R., & Baghai, T. C. (2009) · Der Nervenarzt · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.083 · Cited by 1
Lohse, M. J., Lorenzen, A., & Müller-Oerlinghausen, B. (2008) · Springer eBooks · doi:10.1007/978-3-540-72548-0_42 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.018 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.032 · Cited by 1
(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23672-3.00005-6 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.017 · Cited by 2
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.086 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.046 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.055 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.071 · Cited by 1
Haenel, F. (2002) · Springer eBooks · doi:10.1007/978-3-642-56086-6_11 · Cited by 1
Wu, C. (2010) · Deep Blue (University of Michigan)
Early comorbid parental depression and its effects on child outcomes
Wijlaars, L. P. M. M. (2014) · UCL Discovery (University College London)
Klinisch-therapeutische Wahl des Antidepressivums und Optimierung einer laufenden Behandlung
Laux, G. (2005) · Springer eBooks · doi:10.1007/3-540-28049-9_12
Psicogeriatría: depresión y estilos de afrontamiento
Vega, M. V. R. (2012) · Gredos (University of Salamanca) · doi:10.14201/gredos.121404
Cognitive-Behavioural Therapy Combined with Antidepressants for Major Depressive Disorder
Maneeton, N. (2012) · InTech eBooks · doi:10.5772/30340
DFP: Antidepressive Pharmakotherapie: Aktueller Stand und neue Entwicklungen
Baghai, T., Hp, V., & Hj, M. (2017) · Journal für Kardiologie (Krause & Pachernegg GmbH)
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.004
Essays in the industrial organization of the pharmaceutical industry
Shapiro, B. T. (2014) · DSpace@MIT (Massachusetts Institute of Technology)
Nikander, E. (2004) · Työväentutkimus Vuosikirja
Wpływ escitalopramu, nortryptyliny i wenlafaksyny na objawy bólowe w depresji
Gattner, K. (2014) · Biblioteka Uniwersytetu Medycznego w Poznaniu
Unipolare Depression–Pharmakitherapie und Psychotherapie (ICD-10 F3)
Schmauß, M., Schramm, E., & Berger, T. (2008) · Elsevier eBooks · doi:10.1016/b978-343724780-4.50011-7
Evidenzbasierung und leitliniengestützte Therapie in der Psychiatrie
Möller, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_43
van Calker, D., & Walden, J. (2009) · Elsevier eBooks · doi:10.1016/b978-343722481-2.50009-x
Farmacotherapie bij unipolaire depressiefarmacotherapie stemmingsstoornissen unipolaire
Ruhé, H. G. (2003) · Bijblijven · doi:10.1007/bf03059738
Claes, S. J., & Pieters, G. (2002) · Psychopraxis · doi:10.1007/bf03071974
Smith, H. S., Pappagallo, M., & Stahl, S. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139194464.026
Countering core and co-morbid symptoms of affective disorders: Complementary multi-target strategies
Millan, M. J. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.10.007
Nolen, W. A. (2000) · Evidence-Based Mental Health · doi:10.1136/ebmh.3.4.106
Smith, H. S., Pappagallo, M., & Stahl, S. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139194464.079
Smith, H. S., Pappagallo, M., & Stahl, S. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139194464.019
Akut- und Langzeittherapie der Depression (ICD-10 F3)
BAUER, M., & Möller, H. (2006) · Elsevier eBooks · doi:10.1016/b978-343724130-7.50009-2
Smith, H. S., Pappagallo, M., & Stahl, S. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139194464.051
Treatment options for real-life patients
Parker, G. B. (2004) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500410005540
Hosseini, F., Amini, F., Ardekani, S. M. Y., Shariat, N., & Sakhvidi, M. N. (2015) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.17795/ijpbs1041
Antidepressants and Sleep: Neurophysiology and Clinical Correlates
Iorio, G. D., Marini, S., Acciavatti, T., Melissa, C. M., Vellante, F., Cinosi, E., & Martinotti, G. (2012) · Current Psychiatry Reviews · doi:10.2174/157340012798994885
Zirngibl, C. (2014) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.1000154
Cowen, P. J. (2001) · Evidence-Based Mental Health · doi:10.1136/ebmh.4.2.44
Relation between depression and Omega-3 fatty acids: A study in the Greek population
Vasilios, A. I., Wozniak, G., Ρούπα, Ζ., Odysseas, M. D., & Tsipras, C. (2010) · Journal of Neuroscience and Behavioral Health · doi:10.5897/jnbh.9000025
Improving the clinical effectiveness of antidepressant treatment
Kennedy, S. H. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.044
Is There A Role For “Older” Agents in Child Psychopharmacology?
CARREY, N. J. (2009) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2009.14.3.1
Sato, K., Yoshida, K., Higuchi, H., & Shimizu, T. (2002) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.14.3.357
Stimmungsverändernde Medikamente aus Sicht von Arzt und Patient
Medizin, I. (2005)
Lühike ülevaade mõningatest antidepressantide kliinilist efektiivsust mõjustavatest teguritest
Pokk, P. (2014) · Ajakirjad. Journals by UT · doi:10.15157/ea.v0i0.11732
Major Depressive Disorder and Bipolar Mood Disorders
Lee, K. K. (2015) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.892
Evidence-based choice and antidepressants treatment in psychiatry
Lyubov, E. B., & Ignatenko, S. A. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20151151236-42
Manning, J. (2014) · Cork Open Research Archive (University College Cork, Ireland)
Smith, H. S., Pappagallo, M., & Stahl, S. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139194464.034
A case of syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine
Ahn, H. J., Kim, H. W., Kim, Y. S., Kim, Y. O., Yoon, S. A., & Choi, J. K. (2010) · The Korean Journal of Internal Medicine
The use of venlafaxine at doses higher than 225 mg/day. The balance of risks and benefits
II Klinika Psychiatryczna, O. C. A., & Święcicki, Ł. (2014) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2014.0030
Plattner, A., & Dantz, B. (2011) · Psychopharm Review · doi:10.1097/01.idt.0000392937.51742.dc
Evidence-Based Selection and Use of Antidepressants in Psychiatric Practice
Lyubov, E. B., & Ignatenko, S. A. (2016) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-016-0293-y
Andersen, H. F., Lam, R. W. M., & Kennedy, S. H. (2014) · Ajakirjad. Journals by UT · doi:10.15157/ea.v0i0.9938
Trizyklische Antidepressiva zur Initialbehandlung einer depressiven Episode? Kontra
Adli, M., & Berger, M. (2015) · Der Nervenarzt · doi:10.1007/s00115-015-0032-6
Danilov, D. S., & Korsakov, S. S. (2015) · CyberLeninK (CyberLeninka)
Outcomes in the Treatment of Major Depressive Disorder
Thase, M. E., & Koenig, A. M. (2009) · doi:10.3109/9781420084887-4
Pharmacological Approaches to Treatment-Resistant Depression
D, M. F. M., & Nierenberg, A. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50046-9
Metadata
- Authors
- Anderson, I. M.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Anderson, Ian M.
- ORCID
- Anderson, Ian M.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 58
- Issue
- 1
- Pages
- 19-36
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2101963851
- Cited by
- 940
- References
- 159
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 29 · 2023: 22 · 2022: 19 · 2021: 13 · 2020: 175 · 2019: 18 · 2018: 26 · 2017: 34 · 2016: 23 · 2015: 35 · 2014: 44 · 2013: 36 · 2012: 52
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- selective serotonin reuptake inhibitors, tricyclic antidepressants, depression, antidepressant efficacy, antidepressant tolerability, treatment discontinuation, adverse drug reactions, amitriptyline, fluvoxamine, dothiepin, inpatient care, publication bias
- MeSH terms
- Antidepressive Agents, Tricyclic, Depressive Disorder, Humans, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review